Table 2.
Characteristics of POPPY and AGEh IV PLWH
| POPPY | AGEhIV | |||
|---|---|---|---|---|
| All PLWH (n = 1073) |
PLWH ≥50 (n = 699) | PLWH <50 (n = 374) | PLWH ≥45 (n = 598) |
|
| Gender, No. (%) | ||||
| Male | 914 (85.2) | 612 (87.5) | 302 (80.8) | 524 (87.6) |
| Female | 159 (14.8) | 87 (12.5) | 72 (19.2) | 74 (12.4) |
| Age, median (IQR), y | 52 (47–59) | 57 (53–62) | 43 (37–47) | 53 (48–59) |
| Ethnicity, No. (%)a | ||||
| Black-African | 171 (15.9) | 96 (13.7) | 75 (19.8) | 74 (12.4) |
| White | 902 (84.1) | 603 (86.3) | 299 (80.2) | 513 (85.8) |
| Other/unknown | 0 (0.0) | 0 (0.0) | 0 (0.0) | 11 (1.8) |
| Sexual orientation, No. (%) | ||||
| MSM/homosexual | 816 (76.0) | 548 (78.4) | 268 (71.7) | 369 (70.4) |
| Heterosexual | 257 (24.0) | 151 (21.6) | 106 (28.3) | 177 (29.6) |
| BMI, median (IQR), kg/m2 | 25.5 (23.2–28.2) | 25.7 (23.4–28.5) | 25.2 (23.0–27.8) | 24.3 (22.4–26.7) |
| Duration of HIV, median (IQR), y | 13.2 (7.8–20.5) | 15.8 (9.8–22.4) | 9.7 (5.5–15.2) | 12.0 (6.6–17.0) |
| CD4+ T-cell count, median (IQR), cells/mm3 | 624 (476–811) | 610 (468–792) | 661 (500–847) | 565 (433–740) |
| Nadir CD4+ count, median (IQR), cells/mm3 | 202 (101–304) | 180 (85–273) | 253 (152–376) | 170 (70–260) |
| On ART, No. (%) | 1046 (97.5) | 690 (98.7) | 356 (95.2) | 573 (95.8) |
| HIV RNA <50 copies/mL, No. (%) | 965 (89.9) | 644 (91.8) | 323 (86.4) | 545 (91.6) |
aFor the AGEhIV participants, white refers to Dutch origin, black-African to African origin.
Abbreviations: ART, antiretroviral therapy; BMI, body mass index; IQR, interquartile range; MSM, men who have sex with men; PLWH, people living with HIV.